9FTW | pdb_00009ftw

Crystal structure of calcium-activated EndoU


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.65 Å
  • R-Value Free: 
    0.216 (Depositor) 
  • R-Value Work: 
    0.188 (Depositor) 
  • R-Value Observed: 
    0.190 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9FTW

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Molecular Basis for the Calcium-Dependent Activation of the Ribonuclease EndoU.

Malard, F.Dias, K.Baudy, M.Thore, S.Vialet, B.Barthelemy, P.Fribourg, S.Karginov, F.V.Campagne, S.

(2024) Res Sq 

  • DOI: https://doi.org/10.21203/rs.3.rs-4654759/v1
  • Primary Citation Related Structures: 
    9FTW

  • PubMed Abstract: 

    Ribonucleases (RNases) are ubiquitous enzymes that process or degrade RNA, essential for cellular functions and immune responses. The EndoU-like superfamily includes endoribonucleases conserved across bacteria, eukaryotes, and certain viruses, with an ancient evolutionary link to the ribonuclease A-like superfamily. Both bacterial EndoU and animal RNase A share a similar fold and function independently of cofactors. In contrast, the eukaryotic EndoU catalytic domain requires divalent metal ions for catalysis, possibly due to an N-terminal extension near the catalytic core. In this study, we used biophysical and computational techniques along with in vitro assays to investigate the calcium-dependent activation of human EndoU. We determined the crystal structure of EndoU bound to calcium and found that calcium binding remote from the catalytic triad triggers water-mediated intramolecular signaling and structural changes, activating the enzyme through allostery. Calcium-binding involves residues from both the catalytic core and the N-terminal extension, indicating that the N-terminal extension interacts with the catalytic core to modulate activity in response to calcium. Our findings suggest that similar mechanisms may be present across all eukaryotic EndoUs, highlighting a unique evolutionary adaptation that connects endoribonuclease activity to cellular signaling in eukaryotes.


  • Organizational Affiliation
    • Univ. Bordeaux, CNRS, INSERM, ARNA, UMR 5320, U1212, F-33000 Bordeaux, France.

Macromolecule Content 

  • Total Structure Weight: 94.38 kDa 
  • Atom Count: 4,959 
  • Modeled Residue Count: 554 
  • Deposited Residue Count: 820 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Uridylate-specific endoribonuclease
A, B
410Homo sapiensMutation(s): 0 
Gene Names: ENDOU
EC: 4.6.1 (PDB Primary Data), 3.1 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P21128 (Homo sapiens)
Explore P21128 
Go to UniProtKB:  P21128
PHAROS:  P21128
GTEx:  ENSG00000111405 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP21128
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
EDO

Query on EDO



Download:Ideal Coordinates CCD File
I [auth A]1,2-ETHANEDIOL
C2 H6 O2
LYCAIKOWRPUZTN-UHFFFAOYSA-N
ACT
(Subject of Investigation/LOI)

Query on ACT



Download:Ideal Coordinates CCD File
C [auth A]ACETATE ION
C2 H3 O2
QTBSBXVTEAMEQO-UHFFFAOYSA-M
CA

Query on CA



Download:Ideal Coordinates CCD File
D [auth A]
E [auth A]
F [auth A]
G [auth A]
H [auth A]
D [auth A],
E [auth A],
F [auth A],
G [auth A],
H [auth A],
J [auth B],
K [auth B],
L [auth B],
M [auth B],
N [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.65 Å
  • R-Value Free:  0.216 (Depositor) 
  • R-Value Work:  0.188 (Depositor) 
  • R-Value Observed: 0.190 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 47.723α = 88.62
b = 49.742β = 87.49
c = 60.946γ = 70.35
Software Package:
Software NamePurpose
BUSTERrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Institut National de la Sante et de la Recherche Medicale (INSERM)France--

Revision History  (Full details and data files)

  • Version 1.0: 2024-08-14
    Type: Initial release